Article info

Download PDFPDF

Correction: Toll-like reReceptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16 subset

Citation

Correction: Toll-like reReceptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16 subset

Publication history

  • First published March 17, 2022.
Online issue publication 
March 17, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.